Balyasny Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.4M | Buy |
2,270,076
+634,925
| +39% | +$11.3M | 0.06% | 312 |
|
2025
Q1 | $29.1M | Buy |
1,635,151
+566,288
| +53% | +$10.1M | 0.05% | 350 |
|
2024
Q4 | $31.9M | Buy |
1,068,863
+229,689
| +27% | +$6.84M | 0.05% | 359 |
|
2024
Q3 | $13.1M | Buy |
839,174
+244,176
| +41% | +$3.82M | 0.02% | 587 |
|
2024
Q2 | $10.2M | Buy |
594,998
+167,719
| +39% | +$2.87M | 0.02% | 633 |
|
2024
Q1 | $6.68M | Buy |
427,279
+110,476
| +35% | +$1.73M | 0.01% | 794 |
|
2023
Q4 | $4.73M | Sell |
316,803
-792,812
| -71% | -$11.8M | 0.01% | 797 |
|
2023
Q3 | $17.9M | Buy |
1,109,615
+250,509
| +29% | +$4.05M | 0.04% | 461 |
|
2023
Q2 | $35.7M | Buy |
859,106
+501,077
| +140% | +$20.8M | 0.08% | 293 |
|
2023
Q1 | $21.5M | Buy |
+358,029
| New | +$21.5M | 0.05% | 391 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 2635 |
|
2022
Q2 | – | Sell |
-37,593
| Closed | -$3.12M | – | 2574 |
|
2022
Q1 | $3.12M | Sell |
37,593
-38,373
| -51% | -$3.18M | 0.01% | 901 |
|
2021
Q4 | $5.7M | Buy |
75,966
+66,614
| +712% | +$5M | 0.02% | 682 |
|
2021
Q3 | $1.09M | Buy |
+9,352
| New | +$1.09M | ﹤0.01% | 1091 |
|
2020
Q4 | – | Sell |
-80,588
| Closed | -$8.97M | – | 1381 |
|
2020
Q3 | $8.97M | Sell |
80,588
-280,467
| -78% | -$31.2M | 0.07% | 356 |
|
2020
Q2 | $21.4M | Buy |
+361,055
| New | +$21.4M | 0.19% | 136 |
|
2019
Q3 | – | Sell |
-20,236
| Closed | -$1.28M | – | 1299 |
|
2019
Q2 | $1.28M | Buy |
20,236
+9,189
| +83% | +$581K | 0.01% | 877 |
|
2019
Q1 | $532K | Buy |
+11,047
| New | +$532K | ﹤0.01% | 1087 |
|
2018
Q4 | – | Sell |
-9,165
| Closed | -$480K | – | 1481 |
|
2018
Q3 | $480K | Buy |
+9,165
| New | +$480K | ﹤0.01% | 1174 |
|
2018
Q2 | – | Sell |
-29,036
| Closed | -$633K | – | 1819 |
|
2018
Q1 | $633K | Buy |
+29,036
| New | +$633K | ﹤0.01% | 1189 |
|